Radiation Therapy (XRT) and ZD6474 in Non-Small Cell Lung Cancer (NSCLC)

PHASE1TerminatedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

October 9, 2008

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions
Non-Small Cell Lung Cancer
Interventions
DRUG

ZD6474 (ZACTIMA)

ZD6474 (ZACTIMA) beginning at 100 mg once a day by mouth

RADIATION

Radiation Therapy

"Phase I: 45 Gy at 3 Gy per fractions once a day.~Phase II: 45 Gy at 3 Gy per fraction once a day or 66-70 Gy at 2 Gy per fraction once a day."

Trial Locations (1)

77030

UT MD Anderson Cancer Center, Houston

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

M.D. Anderson Cancer Center

OTHER